Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lindsey A Marsh

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scientific Reports|July 14, 2018
IDPpi: Protein-Protein Interaction Analyses of Human Intrinsically Disordered ProteinsVladimir Perovic, Neven Sumonja, Lindsey A Marsh, et al.
Oncotarget|January 17, 2019
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancerDaphne Brisard, Frank Eckerdt, Lindsey A Marsh, et al.
Cell Death & Disease|May 12, 2017
BASP1 interacts with oestrogen receptor α and modifies the tamoxifen responseLindsey A Marsh, Samantha Carrera, Jayasha Shandilya, et al.
Nature Medicine|November 8, 2016
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expressionDai Horiuchi, Roman Camarda, Alicia Y Zhou, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scientific Reports|July 14, 2018
IDPpi: Protein-Protein Interaction Analyses of Human Intrinsically Disordered ProteinsVladimir Perovic, Neven Sumonja, Lindsey A Marsh, et al.
Oncotarget|January 17, 2019
Antineoplastic effects of selective CDK9 inhibition with atuveciclib on cancer stem-like cells in triple-negative breast cancerDaphne Brisard, Frank Eckerdt, Lindsey A Marsh, et al.
Cell Death & Disease|May 12, 2017
BASP1 interacts with oestrogen receptor α and modifies the tamoxifen responseLindsey A Marsh, Samantha Carrera, Jayasha Shandilya, et al.
Nature Medicine|November 8, 2016
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expressionDai Horiuchi, Roman Camarda, Alicia Y Zhou, et al.
Pageof 1